Taheri Mohsen, Danesh Hiva, Bizhani Fatemeh, Bahari Gholamreza, Naderi Mohammad, Hashemi Mohammad
Genetics of Non-Communicable Disease Research Center, Zahedan University of Medical Sciences, Zahedan 98167-4318, Iran.
Department of Clinical Biochemistry, School of Medicine, Zahedan University of Medical Sciences, Zahedan 98167-4318, Iran.
Biomed Rep. 2019 Apr;10(4):259-265. doi: 10.3892/br.2019.1201. Epub 2019 Mar 15.
Cluster of differentiation (CD)1 molecules are a highly conserved family of MCH-like transmembrane glycoproteins that bind lipid and glycolipid antigens and present a diverse range of microbial and self-glycolipids to antigen-specific T cells. The current study aimed to find out the impact of CD1A and CD1D polymorphisms on pulmonary tuberculosis (PTB). This case-control study encompassed 172 PTB patients and 180 healthy subjects. Genotyping of CD1A and CD1D variants was achieved using the polymerase chain reaction restriction fragment length polymorphism method. The results revealed that CD1A rs411089 variant significantly increased the risk of PTB in recessive model [odds ratio (OR)=2.71, 95% confidence interval (CI)=1.38-5.57, CC vs. TT+TC, P=0.005]. CD1D rs859009 polymorphism significantly reduced the risk of PTB in heterozygous codominant (OR=0.50, 95% CI=0.29-0.86, P=0.011, GC vs. GG) and dominant (OR=0.53, 95% CI=0.31-0.88, P=0.019, GC+CC vs. GG) inheritance model. The CD1A rs366316, CD1D rs973742 and CD1D rs859010 were not associated with the risk/protection from PTB (P>0.05). The results of the present study suggest that CD1A rs411089 and CD1D rs859009 but not CD1A rs366316, CD1D rs973742 and CD1D rs859010 polymorphisms are associated with PTB in a sample of the Iranian population. Further investigation with different ethnicities and larger sample sizes are necessary to certify the findings of the present study.
分化群(CD)1分子是一类高度保守的主要组织相容性复合体(MCH)样跨膜糖蛋白家族,可结合脂质和糖脂抗原,并将多种微生物和自身糖脂呈递给抗原特异性T细胞。本研究旨在探究CD1A和CD1D基因多态性对肺结核(PTB)的影响。这项病例对照研究纳入了172例PTB患者和180名健康受试者。采用聚合酶链反应-限制性片段长度多态性方法对CD1A和CD1D变体进行基因分型。结果显示,在隐性模型中,CD1A rs411089变体显著增加了PTB风险[比值比(OR)=2.71,95%置信区间(CI)=1.38-5.57,CC与TT+TC相比,P=0.005]。在杂合共显性(OR=0.50,95%CI=0.29-0.86,P=0.011,GC与GG相比)和显性(OR=0.53,95%CI=0.31-0.88,P=0.019,GC+CC与GG相比)遗传模型中,CD1D rs859009多态性显著降低了PTB风险。CD1A rs366316、CD1D rs973742和CD1D rs859010与PTB的风险/保护作用无关(P>0.05)。本研究结果表明,在伊朗人群样本中,CD1A rs411089和CD1D rs859009多态性与PTB相关,而CD1A rs366316、CD1D rs973742和CD1D rs859010多态性与PTB无关。需要对不同种族和更大样本量进行进一步研究,以证实本研究结果。